Notice of Charter Renewal, 47834-47835 [2016-17418]

Download as PDF 47834 Federal Register / Vol. 81, No. 141 / Friday, July 22, 2016 / Notices Established 2016 quotas (g) Basic class Proposed revised 2016 quotas (g) Meperidine Intermediate-B ............................................................................................................................. Meperidine Intermediate-C ............................................................................................................................. Metazocine ...................................................................................................................................................... Methadone (for sale) ...................................................................................................................................... Methadone Intermediate ................................................................................................................................. Methamphetamine .......................................................................................................................................... 11 6 19 31,875,000 34,375,000 2,061,375 no no no no no no change. change. change. change. change. change. [1,250,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 750,000 grams for methamphetamine mostly for conversion to a schedule III product; and 61,375 grams for methamphetamine (for sale)] Methylphenidate .............................................................................................................................................. Morphine (for conversion) ............................................................................................................................... Morphine (for sale) ......................................................................................................................................... Nabilone .......................................................................................................................................................... Noroxymorphone (for conversion) .................................................................................................................. Noroxymorphone (for sale) ............................................................................................................................. Opium (powder) .............................................................................................................................................. Opium (tincture) .............................................................................................................................................. Oripavine ......................................................................................................................................................... Oxycodone (for conversion) ........................................................................................................................... Oxycodone (for sale) ...................................................................................................................................... Oxymorphone (for conversion) ....................................................................................................................... Oxymorphone (for sale) .................................................................................................................................. Pentobarbital ................................................................................................................................................... Phenazocine ................................................................................................................................................... Phencyclidine .................................................................................................................................................. Phenmetrazine ................................................................................................................................................ Phenylacetone ................................................................................................................................................ Racemethorphan ............................................................................................................................................ Racemorphan ................................................................................................................................................. Remifentanil .................................................................................................................................................... Secobarbital .................................................................................................................................................... Sufentanil ........................................................................................................................................................ Tapentadol ...................................................................................................................................................... Thebaine ......................................................................................................................................................... 96,750,000 91,250,000 62,500,000 18,750 17,500,000 1,475,000 112,500 687,500 30,000,000 6,250,000 139,150,000 29,000,000 7,750,000 38,125,000 6 50 3 50 3 3 3,750 215,003 6,255 25,500,000 125,000,000 84,375,000. no change. no change. no change. no change. 625,000. no change. 375,000. no change. 5,000,000. no change. 25,000,000. 6,250,000. no change. no change. no change. no change. no change. 5. no change. no change. no change. no change. no change. no change. 100,000 4,000,000 22,400,000 8,500,000 7,000 224,500,000 50,000. no change. 15,000,000. no change. 40. 200,000,000. List I Chemicals Ephedrine (for conversion) ............................................................................................................................. Ephedrine (for sale) ........................................................................................................................................ Phenylpropanolamine (for conversion) ........................................................................................................... Phenylpropanolamine (for sale) ...................................................................................................................... Pseudoephedrine (for conversion) ................................................................................................................. Pseudoephedrine (for sale) ............................................................................................................................ The Acting Administrator further proposes that aggregate production quotas for all other schedule I and II controlled substances included in 21 CFR 1308.11 and 1308.12 remain at zero. In accordance with 21 CFR 1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, the Acting Administrator may adjust the 2016 aggregate production quotas and assessment of annual needs as needed. ehiers on DSK5VPTVN1PROD with NOTICES Conclusion Dated: July 14, 2016. Chuck Rosenberg, Acting Administrator. [FR Doc. 2016–17371 Filed 7–21–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE After consideration of any comments or objections, or after a hearing, if one is held, the Acting Administrator will issue and publish in the Federal Register a final order establishing any adjustment of 2016 aggregate production quota for each basic class of controlled substances in schedules I and II and VerDate Sep<11>2014 established assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, 21 CFR 1303.13(c) and 1315.13(f). 15:19 Jul 21, 2016 Jkt 238001 Notice of Charter Renewal Justice Department. Notice of Charter Renewal of the Executive Advisory Board of the National Domestic Communications Assistance Center. AGENCY: ACTION: PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 In accordance with the provisions of the Federal Advisory Committee Act, title 5, United States Code, Appendix, and title 41 of the U.S. Code of Federal Regulations, section 101–6.1015, notice is hereby given that the Charter of the National Domestic Communications Assistance Center (NDCAC) Executive Advisory Board (EAB) has been renewed. The Charter is on file with the General Services Administration. The Attorney General determined that the NDCAC EAB is in the public interest and is necessary in connection with the performance of duties of the United States Department of Justice. These duties can best be performed through the advice and counsel of this group. The purpose of the EAB is to provide advice and recommendations to the SUMMARY: E:\FR\FM\22JYN1.SGM 22JYN1 Federal Register / Vol. 81, No. 141 / Friday, July 22, 2016 / Notices Attorney General or designee, and to the Director of the NDCAC that promote public safety and national security by advancing the NDCAC’s core functions: law enforcement coordination with respect to technical capabilities and solutions, technology sharing, industry relations, and implementation of the Communications Assistance for Law Enforcement Act (CALEA). The EAB consists of 15 voting members from Federal, State, local and tribal law enforcement agencies. Additionally, there are two non-voting members as follows: a federally-employed attorney assigned full time to the NDCAC to serve as a legal advisor to the EAB, and the DOJ Chief Privacy Officer or designee to ensure that privacy and civil rights and civil liberties issues are fully considered in the EAB’s recommendations. The EAB is composed of eight State, local, and/or tribal representatives and seven federal representatives. The EAB functions solely as an advisory body in compliance with the provisions of the Federal Advisory Committee Act. The Charter has been filed in accordance with the provisions of the Act. Alice Bardney-Boose, Designated Federal Officer, National Domestic Communication Assistance Center, Executive Advisory Board. [FR Doc. 2016–17418 Filed 7–21–16; 8:45 am] BILLING CODE 4410–02–P DEPARTMENT OF JUSTICE ehiers on DSK5VPTVN1PROD with NOTICES Notice of Lodging of Consent Decree Under the Clean Air Act On July 18, 2016, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the Western District of Texas in United States, et al. v Tesoro Refining & Marketing Co. LLC et al. Civil Action No. SA–16–cv–00722. The Consent Decree settles claims brought by the United States, states of Alaska and Hawaii, and the Northwest Clean Air Agency against Tesoro Refining & Marketing Co. LLC, Tesoro Alaska Co. LLC, Tesoro Logistics L.P., and Par Hawaii Refining, LLC for violations of the Clean Air Act, federal regulations promulgated thereunder, and various state regulations and permits at six petroleum refineries located in Kenai, Alaska; Martinez, California; Kapolei, Hawaii; Mandan, North Dakota; Salt Lake City, Utah; and Anacortes, Washington. Under the Consent Decree, Defendants will undertake extensive measures to correct the alleged violations, pay a civil VerDate Sep<11>2014 15:19 Jul 21, 2016 Jkt 238001 penalty of $10,450 to the United States and state co-plaintiffs, and perform three projects to mitigate excess emissions associated with the violations. The publication of this notice opens a period for public comment on the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States et al. v. Tesoro Refining & Marketing Co. LLC et al., D.J. Ref. No. 90–5–2–1–09512/1. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: To submit comments: Send them to: By email ....... pubcomment-ees.enrd@ usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. By mail ......... During the public comment period, the Consent Decree may be examined and downloaded at this Justice Department Web site: https:// www.justice.gov/enrd/consent-decrees. We will provide a paper copy of the Consent Decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ— ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $59.75 (25 cents per page reproduction cost) payable to the United States Treasury. Jeffrey Sands, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2016–17393 Filed 7–21–16; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Office of Justice Programs [OJP (OJJDP) Docket No. 1718] Webinar Meeting of the Federal Advisory Committee on Juvenile Justice Office of Juvenile Justice and Delinquency Prevention, Justice. ACTION: Notice of webinar meeting. AGENCY: The Office of Juvenile Justice and Delinquency Prevention (OJJDP) has scheduled a webinar meeting of the SUMMARY: PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 47835 Federal Advisory Committee on Juvenile Justice (FACJJ). DATES: The webinar meeting will take place online on Tuesday, August 2, 2016, at 1:00 p.m. ET. FOR FURTHER INFORMATION CONTACT: Jeff Slowikowski, Designated Federal Official, OJJDP, Jeff.Slowikowski@ usdoj.gov or (202) 616–3646. [This is not a toll-free number.] SUPPLEMENTARY INFORMATION: FACJJ, established pursuant to Section 3(2)A of the Federal Advisory Committee Act (5 U.S.C. App.2), will meet to carry out its advisory functions under Section 223(f)(2)(C–E) of the Juvenile Justice and Delinquency Prevention Act of 2002. The FACJJ is composed of representatives from the states and territories. FACJJ member duties include: Reviewing Federal policies regarding juvenile justice and delinquency prevention; advising the OJJDP Administrator with respect to particular functions and aspects of OJJDP; and advising the President and Congress with regard to State perspectives on the operation of OJJDP and Federal legislation pertaining to juvenile justice and delinquency prevention. More information on the FACJJ may be found at www.facjj.org. Meeting Agenda: The proposed agenda includes: (a) Opening Introductions, and Webinar Logistics; (b) Remarks of Robert L. Listenbee, Administrator, OJJDP; (c) FACJJ Subcommittee Reports (Legislation; Expungement/Sealing of Juvenile Court Records; Research/Publications; LGBT); (d) FACJJ Administrative Business; and (e) Summary, Next Steps, and Meeting Adjournment. To participate in or view the webinar meeting, FACJJ members and the public must pre-register online. Members and interested persons must link to the webinar registration portal through www.facjj.org, no later than Wednesday, July 27, 2016. Upon registration, information will be sent to you at the email address you provide to enable you to connect to the webinar. Should problems arise with webinar registration, please call Callie Long Murray at 571–308–6617. [This is not a toll-free telephone number.] Note: Members of the public will be able to listen to and view the webinar as observers, but will not be able to participate actively in the webinar. An on-site room is available for members of the public interested in viewing the webinar in person. If members of the public wish to view the webinar in person, they must notify Melissa Kanaya by email message at E:\FR\FM\22JYN1.SGM 22JYN1

Agencies

[Federal Register Volume 81, Number 141 (Friday, July 22, 2016)]
[Notices]
[Pages 47834-47835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17418]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE


Notice of Charter Renewal

AGENCY: Justice Department.

ACTION: Notice of Charter Renewal of the Executive Advisory Board of 
the National Domestic Communications Assistance Center.

-----------------------------------------------------------------------

SUMMARY: In accordance with the provisions of the Federal Advisory 
Committee Act, title 5, United States Code, Appendix, and title 41 of 
the U.S. Code of Federal Regulations, section 101-6.1015, notice is 
hereby given that the Charter of the National Domestic Communications 
Assistance Center (NDCAC) Executive Advisory Board (EAB) has been 
renewed. The Charter is on file with the General Services 
Administration. The Attorney General determined that the NDCAC EAB is 
in the public interest and is necessary in connection with the 
performance of duties of the United States Department of Justice. These 
duties can best be performed through the advice and counsel of this 
group.
    The purpose of the EAB is to provide advice and recommendations to 
the

[[Page 47835]]

Attorney General or designee, and to the Director of the NDCAC that 
promote public safety and national security by advancing the NDCAC's 
core functions: law enforcement coordination with respect to technical 
capabilities and solutions, technology sharing, industry relations, and 
implementation of the Communications Assistance for Law Enforcement Act 
(CALEA). The EAB consists of 15 voting members from Federal, State, 
local and tribal law enforcement agencies. Additionally, there are two 
non-voting members as follows: a federally-employed attorney assigned 
full time to the NDCAC to serve as a legal advisor to the EAB, and the 
DOJ Chief Privacy Officer or designee to ensure that privacy and civil 
rights and civil liberties issues are fully considered in the EAB's 
recommendations. The EAB is composed of eight State, local, and/or 
tribal representatives and seven federal representatives.
    The EAB functions solely as an advisory body in compliance with the 
provisions of the Federal Advisory Committee Act. The Charter has been 
filed in accordance with the provisions of the Act.

Alice Bardney-Boose,
Designated Federal Officer, National Domestic Communication Assistance 
Center, Executive Advisory Board.
[FR Doc. 2016-17418 Filed 7-21-16; 8:45 am]
 BILLING CODE 4410-02-P